the time constant of recovery, the recovery time and tbe ratio hetweeo duration of exercise and recovery time.
Reru//r. Recovery of oxygen consumption was signigcantly delayed in patients, and this delay was relsted lo the deg;rre of -I_-Cardiopulmonary exercise testing is widely used to appreciate exercise tolerance (12). In patients with congestive heart failure. peak oxygen consumption is :I good marker of prog no& and a &ul guide for the timing of cardiac transplantation (3-S) . Curiously, few studies hav; examined the kinettcs of expired gas during recovery in patients with dilated cardiomy opathy. Previous studies have been performed either in normal subjects (6) (7) (8) or in a limited number of patients with dilated cardiomyopathy and with a short recovery period (Y-12). The largest study (12) analyzed the kinetics of oxygen consumption in 72 patients hut in only 13 control subjects and during a short recovery period of 3 mm. Moreovc,r. the clinical relevance of indexes of recovery has never been studied.
The aims of this,study were I) to analyze the kinetics of oxygen consumption during a prolonged recovery period after maximal symptom limited cxercisc in rontrol subjects and in a I---__.-_-_ exercise intolerance. After a median follow-up period of439 days, for the total study group, percent of predicted peak oxygen consumption (p = 0403) and ejection fraction (p = 0.03) were mdependent predictors of survival. In a subgroup of patients with moderate exercise intolerance (percent peek oxygen consumption MO%), the ratio between total oxygen consumption during exercise snd recovery (p = 0.013) and the ejection fraction (p = 0.013) were independent predictors of survtval.
Coo&w&. The kinetics of oxygen consumption during recovery wus delay,d in patients witb dilated eardiomyopatby.
Although indexes of recovery were not proguosttc markers in the total study group, the ratio hetween total oxygen eonsumptlon during exercise and recovery was an independent prognostic marker in patleuts with moderate exercise intolerance.
( and carbon dioxide production) was >I. Exercise was terminated at the point when the participant was unable to corttinue, which for all control subjects was the result of fatigue and for all patients the result of either dyspnea or the leg or general fatigue, or both dyspnea and leg or general fatigue. After the end of exercise, participants remained seated on the bicycle until the respiratory exchange ratio was < 1 For 220 s. In patients, medications were not withdrawn before the test and no patient was taking part in a regular exercise program. Smoking within 2 h before the test was not permitted.
Heart rate was continuously recorded on a 12-lead electrocardiogram (Marquette Electronics Inc. Case 15). Blood pressure was measured every 2 min and at peak exercise with a mercury sphygmomanometer.
The data for gas exchange were collected on a breath by breath basis using a computerized c;stem (Medical Graphics Corporation, CPX system). Oxygen fraction was measured by using a permanent zirconium oxide electrochemical cell and the carbon dioxide fractior was measured by using a dual-beam infrared ab)rption chamber.
Both analyzers were calibrated by using stal;-dard gas mixtures before each exercise test.
Measures. All data for each subject were averaged every 10 s and transferred to a computer for the dctcrmination of several variables (Fig. I) . Oxygen consumption at rest was defined as the average of the last 2 min before the beginr.;ng of excrcisc. Anaerobic threshold was determined by ihc V tlopc method and by analyzing ratio of mrnute ventilation against oq'gen consumption and ratio of minute ven:ilation against carbon dioxide production.
Peak oxygen consumption and peak carbon dioxide production were defined as the average value obtained during the last 10 s of exercise. Predicted value of maximal oxygen consumption was catalated by using the Wasserman equation, normalizing maximal oxygen consump tion for age, gender, weight and height (14) . The oxygen consumption-time relation during recovery was fitted to a monoexponential curve by a nonlinear curve-fittmg pmgrdm by using the equation: Oxygen consur@oo = A+Be", where A and B were constants, t was the Flapsed time after peak exercise and I the time mnstant of rccoveg.
Only curves with %a t
Ese;ereise Reeovery Figure 1 . Example of oxygen consumption (Vo,) and carbon dioxide production (V<'o,) curves during exercise and recovery Lt a control subject and P Fa&nt with stable dilated cardiomyopathy. EPVoL = half-recovery time of p& oxygen consumption; Total Vo, Ex = total oxygen consumption during exercise; Total Vo, Recuv = girl oxygen consumption dur;ag recovery. a cczfficient of correlation >(I.85 were selected for the detcrmination of the time constant of recovery (n = 187). Because no indexes of recovery were clearly defined in published studies, we determined the following indexes ( Fig. 1 ): 1) half-recovery time of peak oxygen consumption. defined as the time needed for peak oxygen consumption to decrease to its half value; 2) recovery time, defined as the time during recovery needed for the respiratory exchange ratio to become <I lC)r 220 continuous seconds; 3) total oxygen consumption during exercise and duting recovery, defined as the areas under oxygen consumption curves during exer&e and during recovery; and 4) time constant of recovery of oxygen consumption. We also calculated the ratio between the duration of exe&e and recovery lime and the ratin between total oxygen consumption during exercise and during recovery CR%,).
St&&es.
Results are presented as mean value 2 SD. Differences between groups were assessed by analysis of variance and by unpaired Student I tests followed by the Student-Newman-Keuls test. Discrete variables were compared using a chi-square analysis. Relation behveen variables were studied by a @ear regression analysis followed by a multilinear regression analysis. *Patients with cardiovascular death or heart transplantation. Data are prwnted as number of patients or mean value ? SD. AT = ailaerobic threshold; F = female; Id = idiopathic; Is = ischemic; LV = left ventricular; M = male; NYHA Ii/III -= New York Heart Assnciation functional class II or 111: 0 = other: RER = respiratory exchange .atio; RRT = rat5 between duration of exe+ and duration of recovety; RT = recovery time; RVo, = ratio betwee; total oxygen consumption during exercise and total oxygen cor,sumption during rcrovery; VE = minute ventilation; Vo, = oxygen consumption; '/zpV% = half-recovery time of peak oxgyen consumption.
Follow-up was performed by direct examination or by contact with the general practitioner or the c.ardiologist. Major end points were cardiovascular death and heart transplantation. The minimal follow-up period was 1 year unless a major end point terminated the follow-up. A Kaplan-Meier method was performed to estimate the cumulative survival. We stratified the population study into two subgroups on the basis of the median value of the variable tested, and a comparative log rank test was used to compare the survival rates of the two wbgroups.
A multivariate Cox pn portional hazards analysis m performed to determine the independent predictors of event-free survival. Quantitative variables were entered as continuous variables. We performed two mult.'v;,riate Cox proportional hazards analysis, the first with all patients and the second with a subgroup of patients with moderate exercise intolerance.. Because the first multivariate Cox analysis selected percent maximal predicted oxygen consumption as the most powerful index predicting survival, in the second analysis we classified the' subjects into two subgroups according to percent maximal predicted oxygen consumption. Statistics were performed with the SAS software version 6.08. A p value ~0.05 was considered statistically significant.
Results
Study gr@~p. We studied 153 patients (139 men, 14 women) with a mean age of 50.1 2 11.5 years (range 21 to 75); their baseline characteristics are presented in Table 1 . Patients were treated with angiotensin-converting enzyme inhibitors (96%), diuretic drugs (95.4%), digoxin (74.5%), amiodarone (28.1%), nitrates (56.2%), anticoagulant agents (35.3%), aspirin (37.9%), beta-adrenergic blocking agents (14.4%) and calcium channel antagonists (3.9%).
Cardiopulmonary exercise test. Results of exercise and postexercise oxygen consumption in the different subgroups are presented in Table 2 . All the indexes of recovery were significantly different between the subgroups. The RVo, was significantly reduced in paiients and all the indexes related to the duration of recovery (half-recovery time of peak oxygen consumption, recovery time, time constant of recovery and the ratio between the duration of exercise and recovery time) were longer in patients thap :n contml subjects. The only significant differences between young and old control subjects were the mean age and the peak oxygen consumption. The values for oxygen consumption at rest and ar the end of recovery were significantly less in the subgroups of patients with a peak oxygen consumption cl5 ml/min per kg (groups 2 and 3) than in control subjects.
Regression analysis. The regression analysis was performed in the total study group (patients and control subjects, n = 208) (Fig. 2) . The different regression coefficients are presented in Table 3 . Peak oxygen consumption was well correlated with duration of exercise (r = 0.87) as was RVo, with ratio between the duration of exercise and recovery time (r = 0.89). The time constant of recovery was correlated with the half-recovery time of peak oxygen consumption (r = 0.63). . ANOVA = analysis of variance; AT = anaerobic threshold: RER = rqiratory exhange ratio: RRT = ratii between duration of excrc:sZ and duration of recovery; RT = recovery time; RVo, = ratio between total oxygen coxwmption during rxerrise and total oqgen wnsumption during recover; tRec = time constant of recover of oxygen consumption; Vco, = ca&m dioxide production: VE = minute rea'ilation: Vo, = ~m;gen commnption; %pVo, = half-recovery time of peak ongyen consumption.
In multiple regression analysis (including the indexes related to the duration of recovery and age), the most closely correlated index of recovery with peak oxygen consumption was the ratio between the duration of exercise and recovery time (F = 142, p < O.OOOl), followed by the recovery time (F = 40, p < O.OOOl), age (F = 28, p < 0.0001) and the half-recovery time of peak oxygen consumption (F = 11.5, p = 0.009). SurvIvaI artaIysI.s. During a median follow-up period of 439 days (range 26 to 1,293) there were 24 cardiovascular deaths and 16 heart transplantations. One patient was lost to follow-up and two deaths were related to cancer. At the end of follow-up, cardiovascular mortality was 15.7% and, including heart transplantation, the event rate was 26%. For the 153 patients with dilated cardiomyopathy, the survival rate was 97.4%, 90.2% and 87.6% at 6,12 and 18 months, respectively. If heart transplantations were included, the event-free survival rate was 91.5%, 83% and 77.8%, respectively (Fig. 3) .
The differences between survivors and 'non survivors" (which induded patients with heart transplantation) are summarized in Table 1 . Table 4 shoivs the results of univariate and multivariate analysis for the 153 patients with dilated cardiomyopathy. The multivariate Con analysis selected percent maximal predicted peak oxygen consumption (p = 0.003) and ejection fraction (p = 0.03) as independent predictors of survival. Peak oxygen consumption normalized for body weight was not an independent predictor of survival.
Patients were classified according to percent maximal predicted oxygen consumption. Among the 35 patients with a percent maximal predicted peak oxygen consumption <40%, the event rate was 60% at the end of the follow-up period (median 336 days, range 26 to 1.038) with 10 cardiac deaths and 11 heart transplantations. The mean age of the patients was 50.9 C 12.5 years; 12 patients were in functional class II and 23 in class III. Mean left ventricular ejection fraction was 22.8 2 10.8%. percent maximal predicted peak oxygen consumption was 34.2 t 5.7% and peak oxygen consumption was 10.3 t 2.6 mumin per kg. In this subgroup. event-free survival was 71.4% at 6 months, 54.3% at iL months and 46% at 18 months (Fig. 3) .
Among the 118 patients with moderate exercise intolerance, there were 14 cardiac deaths and 5 heart transplantations at a median follow-up period of 500 days (range 50 to 1293). The mean age was 49.9 + 11.7 years; 84 patients were in functional class II and 34 were in class III. Mean left ventricularejection fraction was 32 2 t 11.5%, peak oxygen consump tion was 17.3 C 4.2 ml/min per kg and percent maximal predicted peak oxygen consumption was 59.7 -C 13.4%. Eventfree survival at 6,12 and 18 months was 975.92.4 and 873%, Scatterplots showing all individual values (patients with dilated cardiomyopathy and control subjects, n = 208) for indexes of recovery and peak oxygen consumption (peak Vo,). Top, Ratio behveen exercise duration and recovery time (RRT) plotted against peak Voz. Middle, Half-recovery time of peak oxygen consumption (EPeakVoJ plotted against peak oxygen consumption. Bottom, Ratio behveen total oxygen consumption during exercise and total oxygen consumption during recovery (RVo,) plotted against ratio between exercise duration and recovery time.
respectively (Fig. 3) . Table 5 shows the results of the univariate and muitivariate analysis in this subg-oup. Mtthivariate Cox analysis selected only two independet, predictors oi survival: RVoz (p = 0.013) and ejection fraction (p = 0.013). Figure 4 shows the survival curve in this subgroup of patients stratified by RVo, (>2.5 or ~2.5) and by ejection fraction (>Bt% or <30%). The median value of RVoz was 2.5. In this subgroup, 14 patients (74%) with a major event had an RVo, c2.5. Survival is better when RVoz is >2.5, whatever the value of the ejection fraction.
Discussion
Our study demonstrates in a large group of patients with stable dilated cardiomyopathy that the kinetics of oxygen consumption during recovery are delayed compared with values in a control group. Moreover, RVo?, an index analyzing exercise and recovery periods, predicts survival in a subgroup of patients with moderate risk of major cardiac events.
Indexes of recovery. In normai subjects. oxygen consump tion after maximal exercise shows an exponential, decline toward the rest baseline level (6, 7) . In previous studies (9-12), the kinetics of oxygen consumption were studied during a short recovery Period (2 to 4 min), in a limited number of patients (15 to 72) and control subjects (CM) or after submaximal exercise. We defined several indexes analyzing the recovery period alone (half-recovery time of peak oxygen consumption. recovery time and the time constant of recovery) but also indexes analyzing the exercise and the recovery periods (ratio between the duration of exercise and recovery time and RVo,). RVo,, the ratio between total oxygen consumption during exercise and during recovery, gives a good idea of the relation between oxygen, consumption during exercise and during recovery. The mechanism of the rf-every of oxygen consumption is not fully understood. Indexes of recovery were not correlated with ejection fraction, suggesting that the kinetics of oxygen consumption during recovery were mainly related to peripheral factors. Patients with congestive heart failure have reduced oxygen stores, impaired oxygen transport and muscle metabolism as well as muscle atrophy (15) (16) (17) (18) (19) . The mechanism underlying exercise intolerance is probably the same as the one explaining the delay in recovery. The decline in oxygen consumption is subdivided into a fast component followed by a slow one (7). The half-recovery time of peak oxygen consumption (and the time constant of recovery) Fire 3. Event-free sttrvivtal curves for the total study group (bold line) and for the subgroups of patients with a percent maximal predicted oxygen consumption (Vo,) ~40% (lit line) or <GO% ($lashr!d he). too - There is no relation between the slow comF.ment and the excess production of lactates (20.21) or the increase in catecholamines (11) . In our stu.ly. patients with a peak cqgen cousumption 45 ml/min per kg (groups 2 and 3) had significantly lower values for oxygen consumption at resi (baseline) and at the end of recovery than did control subjects and patients in group 1. This could explain the delay of the sknv component of recovery, but further studies are required to Training increases the rate of recovery in normal subjects (22) , and a similar response is expected in patients with congestive heart failure in whom muscle deconditioning remains a major problem. Age plays a role in determining exercise capacity and recovery of oxygen consumption, but its role is probably not dominant. There were significant differences in indexes of recovery between old control subjects and patients despite similar mean age. In contrast, all the indexes of recovery were similar in young and old control subjects.
Smvlval analysis.
One important finding of our study is that peak oxygen consumption normalized for body weight was not an independent prognostic marker when it was compared with percent maximal predicted oxygen consumption. 'Predieted value of maximal oxygen consumption, lvhich takes into account age, gender, height and weight, is more precise than peak oxygen consumptiottikg (14) . In most previous studies, percent maximal predicted oxygen consumption was not compared with peak oxygen consumption/kg (3-523-25 (26) . In patients with dilated cardiomyopathy in stage II to IV (New York Heart Association classification) percent maximal predicted oxygen consumption is a more powerful predictor of cardiac events than peak oxygen consumption normalized for body weight. Moreover. it is also more powerful than left ventricular ejection fraction. which is a good predictor of survival (23, 24, 27, 28) .
However, in a subgroup of patients with a low risk of major cardiac events, percent maximal predicted oxygen consumption and peak oxygen consumption/kg failed to predict survival. The prognostic information given by peak oxygen consumption is evident when the value is ~1tJ ml/min per kg (3, 4, 27, 29) . In our subgroup of patients with a percent maximal predicted oxygen consomption :40%, mean peak oxygen consumption/kg was 10.3 2 2.6 mlimin per kg. This cutoff value (40%) selected the most severely ill patients with a cardiovascular event rate of 45.7% at I year. Heart transplantation represented 52.4% of these cardiovascular events. It is possible that the result of the cardiopulmonary exercise test guided the physicians in patient management.
In patients with a percent maximal predicted oxygen consumption >4O%, the event-free survival rate was 92.4% at I2 months. Despite this low event rate, the only index of the exercise test that provided prognostic information was RVo,. RVo, analyzes the kinetics of oxygen consumption during exercise and during recovery. Figure 4 clearly shows that survival is better in patients with an RVo, >2.5 than in patients with an RVoz ~2.5, whatever the value of ejection fraction. A patient with a moderate exercise. intolerance and with a short recovery period has a better prognosis than a patient with a long recovery period. We recommend that RVo, be determined in all patients with moderate exercise intolerance (percent maximal predicted oxygen consumption >40%) to increase the prognostic value of the results of the cardiopulmonaty exercise test. Patients with an RVoz C2.5 must be followed up carefully because of the increased risk of major cardiac events. in patients with a percent maximal predicted oxygen consumption <40%, RVo2 or other indexes of recovety are not useful. Our study demonstrates that 1) the kinetics of oxygen consumption aiter maximal exercise were delayed in patients with stable dilated cardiomyopathy compared to controls and this delay was related to the degree of exercise intolerance;
2) for all patients, percent maximal predicted value of oxygen consumption and left ventricular ejection fraction were independent predictors of survival; 3) in patients with moderate exercise intolerance (peak oxygenconsumption >40%), RVo2 and left ventricular ejection fraction were independent predictors of survival.
